Cellnex
ESRS disclosure: ESRS E4 \ DR E4-1 \ Paragraph 15
Tags Tree
- Provide the transition plan detailing how the business model and strategy will be aligned with the Kunming-Montreal Global Biodiversity Framework, the EU Biodiversity Strategy for 2030, and the planetary boundaries concerning biosphere integrity and land-system change.
-
Question Id: E4-1_07
The nature strategy shall include both the own operations and the value chain, to effectively collaborate with other stakeholder to improve the nature performance. The nature strategy will consist of a practical transition plan, with specified actions and targets per business unit and country. It is to be developed not only to determine new actions to be taken, but also to align already existing initiatives and policies across the organisation.
Report Date: 4Q2024Relevance: 60%
- Does the target address any shortcomings related to the Substantial Contribution criteria for Biodiversity, as defined in the delegated acts pursuant to Article 15(2) of Regulation (EU) 2020/852? Additionally, if the Do No Significant Harm (DNSH) criteria for Biodiversity, as outlined in the delegated acts pursuant to Articles 10(3), 11(3), 12(2), 13(2), and 14(2) of Regulation (EU) 2020/852, are not met, does the target address any shortcomings related to these DNSH criteria?
-
Question Id: E4-4_10
Cellnex has committed to a series of policies and objectives related to nature. These commitments have been included in the ESG strategy and form part of the company's efforts to mitigate its impacts and risks related to nature. However, it is still pending to link these commitments to quantifiable objectives and specific goals.
Report Date: 4Q2024Relevance: 50%